Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane E Angermann

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
European Heart Journal|October 18, 2022
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trialJan Biegus, Adriaan A Voors, Sean P Collins, et al.
JAMA|July 2, 2016
Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical TrialChristiane E Angermann, Götz Gelbrich, Stefan Störk, et al.
European Journal of Heart Failure|October 5, 2022
Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HFWouter Ouwerkerk, Jasper Tromp, John G F Cleland, et al.
European Journal of Heart Failure|April 4, 2024
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trialJasper Tromp, Mikhail N Kosiborod, Christiane E Angermann, et al.
JACC. Heart Failure|March 7, 2026
Empagliflozin in De Novo vs Acute Decompensated Chronic Heart Failure: A Prespecified Analysis From EMPULSEChristiane E Angermann, Teresa Gerhardt, Jonathan P Blatchford, et al.
Heart Failure Reviews|June 19, 2026
Left ventricular non-compaction in heart failure: contemporary perspective on diagnostic challenges and treatment opportunitiesOliviana Geavlete, Carsten Tschöpe, Christiane E Angermann, et al.
European Journal of Heart Failure|February 20, 2021
Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trialJasper Tromp, Piotr Ponikowski, Afshin Salsali, et al.
European Journal of Heart Failure|September 6, 2022
Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trialAdriaan A Voors, Kevin Damman, John R Teerlink, et al.
American Heart Journal|September 13, 2021
A global perspective of racial differences and outcomes in patients presenting with acute heart failureJasper Tromp, Wouter Ouwerkerk, John G F Cleland, et al.
ESC Heart Failure|August 31, 2023
Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registrySpyridon Katsanos, Wouter Ouwerkerk, Dimitrios Farmakis, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
European Heart Journal|October 18, 2022
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trialJan Biegus, Adriaan A Voors, Sean P Collins, et al.
JAMA|July 2, 2016
Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical TrialChristiane E Angermann, Götz Gelbrich, Stefan Störk, et al.
European Journal of Heart Failure|October 5, 2022
Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HFWouter Ouwerkerk, Jasper Tromp, John G F Cleland, et al.
European Journal of Heart Failure|April 4, 2024
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trialJasper Tromp, Mikhail N Kosiborod, Christiane E Angermann, et al.
JACC. Heart Failure|March 7, 2026
Empagliflozin in De Novo vs Acute Decompensated Chronic Heart Failure: A Prespecified Analysis From EMPULSEChristiane E Angermann, Teresa Gerhardt, Jonathan P Blatchford, et al.
Heart Failure Reviews|June 19, 2026
Left ventricular non-compaction in heart failure: contemporary perspective on diagnostic challenges and treatment opportunitiesOliviana Geavlete, Carsten Tschöpe, Christiane E Angermann, et al.
European Journal of Heart Failure|February 20, 2021
Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trialJasper Tromp, Piotr Ponikowski, Afshin Salsali, et al.
European Journal of Heart Failure|September 6, 2022
Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trialAdriaan A Voors, Kevin Damman, John R Teerlink, et al.
American Heart Journal|September 13, 2021
A global perspective of racial differences and outcomes in patients presenting with acute heart failureJasper Tromp, Wouter Ouwerkerk, John G F Cleland, et al.
ESC Heart Failure|August 31, 2023
Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registrySpyridon Katsanos, Wouter Ouwerkerk, Dimitrios Farmakis, et al.
Pageof 14